Skip to main content
Clinical Trials/EUCTR2006-006181-42-NL
EUCTR2006-006181-42-NL
Active, not recruiting
Not Applicable

The use of USPIO enhanced MRI in the assessment of axillary lymph node status in patients with invasive breast cancer - The USPALS trial

MC St Radboud0 sites440 target enrollmentDecember 1, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The presence of axillary metastasis in patients with proven invasive breast cancer
Sponsor
MC St Radboud
Enrollment
440
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
MC St Radboud

Eligibility Criteria

Inclusion Criteria

  • nclusion criteria
  • \- Histologically proven invasive breast cancer
  • \- Surgical removal of at least 1 axillary lymph node will be performed
  • \- Patient must be accessible for treatment
  • \- Patient must provide written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes

Exclusion Criteria

  • Exclusion criteria
  • \- Patient age under 18
  • \- Karnofsky score equal to or under 70
  • \- Pregnant or lactating women
  • \- Patients with conta\-indications for MRI scanning (e.g. pacemaker, claustrophobia, ferromagnetic objects in the eyes or brain)
  • \- Patients with contra\-indications for the use of USPIO based contrast agents or dextran (e.g. known allergy)
  • \- Male gender

Outcomes

Primary Outcomes

Not specified

Similar Trials